Progression-free survival was significantly greater in the nivolumab plus ipilimumab group compared to nivolumab alone. 2. Treatment-related adverse events were slightly higher in nivolumab plus ...

Real world data show that immunotherapy leads to better overall survival outcomes than chemotherapy in patients with ...

Favorable initial results from a phase 1/2 trial of solnerstotug in PD-L1–resistant tumors showed a 14% response rate and 62% ...

Durable complete response (CR) in a MCC patient treated with 15 mg/kg solnerstotug + cemiplimab. Patient continues on ...

A phase 2 trial will evaluate leronlimab’s safety and efficacy for the treatment of patients with microsatellite stable ...

A major scientific leap has been made with the creation of the longest ultra-secure quantum satellite link between China and ...

The firm says it has a path forward for a Phase II/III registration-enabling study of NOUS-209 after positive meetings with the FDA.

Scientists in China have transmitted encrypted images a record 12,900 kilometers, paving the way for quantum messaging ...

Leap Therapeutics (LPTX) presented updated preliminary data from Part B of the DeFianCe study, a Phase 2, open-label, global study of ...

Patients with MSI-H mCRC had a higher probability of survival with first-line ICI therapy than with chemotherapy, but second-line or later ICIs did not confer the same benefit.

Chinese researchers have made a major breakthrough by developing the world's first quantum microsatellite and demonstrating real-time QKD between the satellite and multiple compact, mobile ground ...

Researchers used a small, light device and portable ground stations to set a record in communications Researchers from China ...